[go: up one dir, main page]

WO2001060840A3 - Estimation des proteines/de la solubilite et du repliage par complementation structurelle - Google Patents

Estimation des proteines/de la solubilite et du repliage par complementation structurelle Download PDF

Info

Publication number
WO2001060840A3
WO2001060840A3 PCT/US2001/005097 US0105097W WO0160840A3 WO 2001060840 A3 WO2001060840 A3 WO 2001060840A3 US 0105097 W US0105097 W US 0105097W WO 0160840 A3 WO0160840 A3 WO 0160840A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
folding
improper
marker protein
protein solubility
Prior art date
Application number
PCT/US2001/005097
Other languages
English (en)
Other versions
WO2001060840A2 (fr
Inventor
Philip Jordan Thomas
John F Hunt
William Christian Wigley
Rhesa D Stidham
Original Assignee
Univ Texas
Univ Columbia
Philip Jordan Thomas
John F Hunt
Rhesa D Stidham
William Christian Wigley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Univ Columbia, Philip Jordan Thomas, John F Hunt, Rhesa D Stidham, William Christian Wigley filed Critical Univ Texas
Priority to EP01909281A priority Critical patent/EP1257829B1/fr
Priority to JP2001560224A priority patent/JP4772247B2/ja
Priority to DK01909281T priority patent/DK1257829T3/da
Priority to CA2398834A priority patent/CA2398834C/fr
Priority to DE60123755T priority patent/DE60123755T2/de
Priority to AU3705501A priority patent/AU3705501A/xx
Priority to AU2001237055A priority patent/AU2001237055B2/en
Publication of WO2001060840A2 publication Critical patent/WO2001060840A2/fr
Publication of WO2001060840A3 publication Critical patent/WO2001060840A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Plusieurs protéines, lorsqu'elles sont produites par recombinaison, souffrent d'un traitement et d'un repliage non appropriés et manquent de solubilité normale. Les protéines modifiées, y compris celles indiquant des états pathologiques peuvent également avoir ces défauts. La présente invention concerne des procédés pour identifier le repliage approprié ou non approprié, un traitement erroné et/ou l'insolubilité. Le procédé est fondé sur l'utilisation de deux composants: une protéine de fusion spécialisée et une complémentation structurelle. La protéine de fusion contient des séquences provenant de la protéine d'intérêt et une partie de la protéine de marquage qui elle-même n'est pas active. Une cellule hôte fournit le reste de la protéine de marquage qui sert à 'complémenter' la fonction de la protéine de marquage fusionnée de manière à ce que leur association rétablisse l'activité en permettant la détection.
PCT/US2001/005097 2000-02-14 2001-02-14 Estimation des proteines/de la solubilite et du repliage par complementation structurelle WO2001060840A2 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EP01909281A EP1257829B1 (fr) 2000-02-14 2001-02-14 Estimation de la solubilite et du repliage des proteines par complementation structurelle
JP2001560224A JP4772247B2 (ja) 2000-02-14 2001-02-14 タンパク質の溶解性及びフォールディングを評価する相補性アッセイ
DK01909281T DK1257829T3 (da) 2000-02-14 2001-02-14 Komplementationsassay der vurderer proteinoplöselighed og -foldning
CA2398834A CA2398834C (fr) 2000-02-14 2001-02-14 Repliement proteique/de solubilite evalue par complementation structurale
DE60123755T DE60123755T2 (de) 2000-02-14 2001-02-14 Komplementierungsassay für den nachweis von protein-löslichkeit und -faltung
AU3705501A AU3705501A (en) 2000-02-14 2001-02-14 Protein/solubility folding assessed by structural complementation
AU2001237055A AU2001237055B2 (en) 2000-02-14 2001-02-14 Complementation assay assessing protein solubility and folding

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18228300P 2000-02-14 2000-02-14
US60/182,283 2000-02-14
US77505100A 2001-01-31 2001-01-31
US09/775,051 2001-01-31

Publications (2)

Publication Number Publication Date
WO2001060840A2 WO2001060840A2 (fr) 2001-08-23
WO2001060840A3 true WO2001060840A3 (fr) 2002-04-25

Family

ID=22667801

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/005097 WO2001060840A2 (fr) 2000-02-14 2001-02-14 Estimation des proteines/de la solubilite et du repliage par complementation structurelle

Country Status (1)

Country Link
WO (1) WO2001060840A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9511074B2 (en) 2009-08-03 2016-12-06 University of Pittsburgh—of the Commonwealth System of Higher Education Methods of treating disorders associated with protein polymerization
US9844605B2 (en) * 2009-11-05 2017-12-19 The University of Pittsburgh—Of the Commonwealth System of Higher Education Transgenic Caenorhabditis elegans comprising a human protein with a tendency to aggregate fused to a fluorescent protein

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2883886B1 (fr) * 2005-04-05 2010-12-03 Biomethodes Methode d'obtention de variants solubles ou mieux exprimes d'une proteine d'interet
CN101443460B (zh) 2006-03-13 2013-03-06 利兰·斯坦福青年大学托管委员会 利用降低亲和力酶互补报告分子系统检测分子间相互作用
US8101373B2 (en) 2007-10-12 2012-01-24 Discoverx Corporation β-galactosidase donor fragments
US9072772B2 (en) 2009-11-05 2015-07-07 University of Pittsburgh—of the Commonwealth System of Higher Education Methods of treating disorders associated with protein aggregation
CA2840269C (fr) 2011-06-23 2015-08-18 Discoverx Corporation Suivi du trafic des proteines par complementation d'un fragment rapporteur de beta-galactosidase

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034120A1 (fr) * 1997-01-31 1998-08-06 Universite De Montreal Analyses par complementation de fragments proteiques pour detecter des interactions biomoleculaires
WO1998044350A1 (fr) * 1997-04-02 1998-10-08 The Board Of Trustees Of The Leland Stanford Junior University Detection d'interactions moleculaires par complementation de sous-unites de marquage

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034120A1 (fr) * 1997-01-31 1998-08-06 Universite De Montreal Analyses par complementation de fragments proteiques pour detecter des interactions biomoleculaires
WO1998044350A1 (fr) * 1997-04-02 1998-10-08 The Board Of Trustees Of The Leland Stanford Junior University Detection d'interactions moleculaires par complementation de sous-unites de marquage

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ABBAS-TERKI TOUFIK ET AL: "alpha-complemented beta-galactosidase. An in vivo model substrate for the molecular chaperone heat-shock protein 90 in yeast.", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 266, no. 2, December 1999 (1999-12-01), pages 517 - 523, XP002182770, ISSN: 0014-2956 *
CAMPBELL VALOIS F -X ET AL: "Utilisation of the PCA strategy to study the folding of the RBD of raf.", FASEB JOURNAL, vol. 13, no. 7, 23 April 1999 (1999-04-23), Annual Meeting of the American Societies for Experimental Biology on Biochemistry and Molecular Biology 99;San Francisco, California, USA; May 16-20, 1999, pages A1387, XP002182768, ISSN: 0892-6638 *
JOHNSSON N ET AL: "SPLIT UBIQUITIN AS A SENSOR OF PROTEIN INTERACTIONS INV VIVO", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 91, 1 October 1994 (1994-10-01), pages 10340 - 10344, XP002064564, ISSN: 0027-8424 *
KO Y H ET AL: "THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR. OVEREXPRESSION, PURIFICATION, AND CHARACTERIZATION OF WILD TYPE ANDDELTAF508 MUTANT FORMS OF THE FIRST NUCLEOTIDE BINDING FOLD IN FUSION WITH THE MALTOSE-BINDING PROTEIN", CELL, CELL PRESS, CAMBRIDGE, NA, US, vol. 268, no. 32, 15 November 1993 (1993-11-15), pages 24330 - 24338, XP002055212, ISSN: 0092-8674 *
NIXON ANDREW E ET AL: "Improvement in the efficiency of formyl transfer of a GAR transformylase hybrid enzyme.", PROTEIN ENGINEERING, vol. 13, no. 5, May 2000 (2000-05-01), pages 323 - 327, XP002182771, ISSN: 0269-2139 *
WALDO GEOFFREY S ET AL: "Rapid protein-folding assay using green fluorescent protein", NATURE BIOTECHNOLOGY, vol. 17, July 1999 (1999-07-01), pages 691 - 695, XP002182769 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9511074B2 (en) 2009-08-03 2016-12-06 University of Pittsburgh—of the Commonwealth System of Higher Education Methods of treating disorders associated with protein polymerization
US9844605B2 (en) * 2009-11-05 2017-12-19 The University of Pittsburgh—Of the Commonwealth System of Higher Education Transgenic Caenorhabditis elegans comprising a human protein with a tendency to aggregate fused to a fluorescent protein

Also Published As

Publication number Publication date
WO2001060840A2 (fr) 2001-08-23

Similar Documents

Publication Publication Date Title
DK1257829T3 (da) Komplementationsassay der vurderer proteinoplöselighed og -foldning
EP0960939A3 (fr) Protéines doublemment étiquettées et leurs utilisations
EP1634966A3 (fr) Procédé de détection de séquences d'acides nucléiques dans de l'urine
WO2001012662A3 (fr) Proteines associees a la membrane
DE69933661D1 (de) Genomische sequenz des 5-lipoxygenase-aktivierenden proteins (flap), polymorphische marker und ihre anwendung in der diagnose von asthma
DE60026332D1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
ES2109982T3 (es) Procedimiento y composiciones de ensayo para determinar proteasas en suero, particularmente proteina c activada.
BR9812783A (pt) "sistemas de detecção para o registro de interações e as relações funcionais de proteìnas"
WO2001060840A3 (fr) Estimation des proteines/de la solubilite et du repliage par complementation structurelle
WO2000018922A3 (fr) Proteines humaines associees a des glucides
WO2000009709A3 (fr) Proteases et proteines associees
ATE392620T1 (de) Nachweismittel von patologischen veränderungen des proteins app und ihre verwendungen
AU2126400A (en) Detection of small molecules by use of a piezoelectric sensor
CA2234416A1 (fr) Determination immunochimique d'analytes multivalents
WO2003012393A3 (fr) Procede de detection de l'activite de la protease dans une cellule
WO1999033981A3 (fr) Proteines contenant des sequences-signaux humaines
WO2001077305A3 (fr) Variantes de la sous-unite gamma-3 humaine de la proteine kinase activee par l'amp
WO2000001821A3 (fr) Proteines associees a la neurotransmission
WO2004113566A3 (fr) Reseau de proteines associees a une maladie
WO2000011171A3 (fr) Proteines humaines associees a l'arn
CA2155001A1 (fr) Peptides derives de htlv-i et htlv-ii gp21, utilisables dans les diagnostics
WO2001046256A3 (fr) Proteines circulant par l'intermediaire de vesicules
WO2000018915A3 (fr) Proteines organisationnelles associees aux membranes
WO2000017358A3 (fr) Proteines chaperons humaines
WO2000071679A3 (fr) Proteines d'oxydoreductase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001237055

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2398834

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 560224

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001909281

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001909281

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2001909281

Country of ref document: EP